Replies to post #4527 on RespireRx Pharmaceuticals Inc (fka RSPI)

[Aiming4]

Erick - you have high standards!... COR is already up almost 100% from the $1.07 level.

Will you be interested in adding more COR if the FDA gives the green light to CX717?

I think the post-positive FDA decision and pre-partnership deal(s) period will be "easy money" time for COR investors.

Hopefully there will be even more of a run up from the current $2.00 level; it creates a greater buffer in case of a bad decision from the FDA.

And a greater springboard base in case the decision is positive.. Aiming4.

[gfp927z]

Erik, It looks like Neuro is figuring the odds of a good FDA decision at approx 80-90%, which is where I'd put them also. Would you care to go on record with a prediction?

I'd also be interested in your current "stocks of interest" list. I assume you still like Medarex? I've always considered them a core holding also. I remember you always had interesting stock ideas, including Cortex when it was really obscure.